Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Justices' Ruling Empowers FDA To Rein In Vapes, Experts Say No Photo Available

Sam Reisman

A unanimous U.S. Supreme Court decision affirming federal regulators' authority to deny marketing applications for flavored vapes was ... (more story)

5 Fed. Circ. Clashes To Watch This Month No Photo Available

Ryan Davis

The Federal Circuit will hear arguments this month in patent cases involving Moderna's COVID-19 vaccine and a blockbuster Johnson & Jo... (more story)

Unregulated Health Cost 'Ministries' Attract State Scrutiny No Photo Available

Hannah Albarazi

Offering a cheap alternative to traditional health insurance and a faith-based approach, health cost "sharing ministries" operate acro... (more story)